M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Carisma Therapeutics Inc. to acquire OrthoCellix
Announced Jun 23, 2025 · Terminated Sep 18, 2025 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Carisma Therapeutics Inc. (CARM)
- Target
- OrthoCellix
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Terminated Sep 18, 2025
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations